Metagenomi, Inc.
MGX
$1.67
$0.159.87%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -21.27% | 5.28% | 17.44% | -55.88% | -31.91% |
| Total Depreciation and Amortization | 21.65% | 18.20% | 29.48% | 51.37% | 67.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 492.91% | 76.96% | 197.55% | 784.60% | 3,637.74% |
| Change in Net Operating Assets | -253.36% | -80.82% | -104.81% | -119.01% | -105.35% |
| Cash from Operations | -27.60% | -12.25% | -0.83% | -42.18% | -130.40% |
| Capital Expenditure | 80.77% | 46.88% | 78.89% | 65.70% | 50.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -53.70% | -109.90% | 20.54% | -35.18% | 276.35% |
| Cash from Investing | -52.92% | -111.77% | 30.36% | -31.45% | 255.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.00% | 74.24% | -5,110.26% | 1,914.83% | -101.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -94.14% | -171.77% | 7.74% | 57.14% | -68.82% |